LANA GOODMAN: Open Payments
NPI 1528509825 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$860 in 45 payments from 13 companies in 2025. Trend: 2023 $1,746 · 2024 $1,695 · 2025 $860
Food & beverage: $860
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $174 |
| LEO Pharma Inc. | 9 | $138 |
| Regeneron Healthcare Solutions, Inc. | 4 | $118 |
| ABBVIE INC. | 5 | $94 |
| UCB, Inc. | 3 | $75 |
| GENZYME CORPORATION | 2 | $61 |
| Galderma Laboratories, L.P. | 2 | $41 |
| Botanix SB Inc | 2 | $33 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $33 |
| Organon LLC | 2 | $33 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, Bimzelx, ANZUPGO, ADBRY, SOFDRA, ILUMYA.
Industry payments across TN — which companies pay providers there.
